The U.S. Health Resources and Services Administration (HRSA) has received 59 comments in response to its request for information (RFI) regarding ‘training and care delivery models for safe administration of potential FDA-approved psychedelic therapies in ambulatory settings.’ HRSA, which is housed in the Department of Health and Human Services is, in some respects, a lesser-known federal agency.
